OUD Findings from Medicaid Enrollees
JAMA reports a noted increase in opioid use disorder treatments in those enrolled in Medicaid. The study looked at over a million enrollees from 11 states: medication treatment prevalence in 2014 was 47.8% and in 2018, 57.1%. Of note, use of OUD medication was higher in pregnant women and white enrollees than non-Hispanic black enrollees.
The medications used in the study were buprenorphine, methadone, or naltrexone. The study concludes that “the pattern in the other states is not known” and merits further research.
Access the journal.
Did you enjoy this article?
Subscribe to the PAINWeek Newsletter
and get our latest articles and more direct to your inbox